Watson RC - Search Results

1

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, et al. Sternberg CN, et al. Among authors: watson rc. Cancer. 1989 Dec 15;64(12):2448-58. doi: 10.1002/1097-0142(19891215)64:12<2448::aid-cncr2820641209>3.0.co;2-7. Cancer. 1989. PMID: 2819654

2

M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Darshaw D, Reuter V, et al. Scher H, et al. Prog Clin Biol Res. 1990;353:179-86. Prog Clin Biol Res. 1990. PMID: 2217417 No abstract available.

3

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V, et al. Scher H, et al. Br J Urol. 1989 Sep;64(3):250-6. doi: 10.1111/j.1464-410x.1989.tb06008.x. Br J Urol. 1989. PMID: 2804561

4

Chemotherapeutic management of invasive bladder carcinoma.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Geller N, et al. Sternberg CN, et al. Among authors: watson rc. Eur Urol. 1988;14 Suppl 1:19-20. doi: 10.1159/000473033. Eur Urol. 1988. PMID: 3053199 Clinical Trial. No abstract available.

5

M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Whitmore WF Jr, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Fair WR. Sternberg CN, et al. Among authors: watson rc. Prog Clin Biol Res. 1988;260:481-5. Prog Clin Biol Res. 1988. PMID: 3283768 Clinical Trial. No abstract available.

6

Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.

Sternberg CN, Yagoda A, Scher HI, Whitmore WF Jr, Herr HW, Morse MJ, Sogani PC, Bosl G, Watson RC, Hollander PS, et al. Sternberg CN, et al. Among authors: watson rc. Prog Clin Biol Res. 1988;260:551-5. Prog Clin Biol Res. 1988. PMID: 3283770 Review. No abstract available.

7

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, et al. Sternberg CN, et al. Among authors: watson rc. J Urol. 1988 Mar;139(3):461-9. doi: 10.1016/s0022-5347(17)42494-3. J Urol. 1988. PMID: 3343727

8

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

Scher HI, Yagoda A, Herr HW, Sternberg CN, Bosl G, Morse MJ, Sogani PC, Watson RC, Dershaw DD, Reuter V, et al. Scher HI, et al. Among authors: watson rc. J Urol. 1988 Mar;139(3):470-4. doi: 10.1016/s0022-5347(17)42495-5. J Urol. 1988. PMID: 3343728

9

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.

Scher HI, Yagoda A, Herr HW, Sternberg CN, Morse MJ, Sogani PC, Watson RC, Reuter V, Whitmore WF Jr, Fair WR. Scher HI, et al. Among authors: watson rc. J Urol. 1988 Mar;139(3):475-7. doi: 10.1016/s0022-5347(17)42496-7. J Urol. 1988. PMID: 3343729

10

Vinblastine and methotrexate for advanced bladder cancer.

Ahmed T, Yagoda A, Needles B, Scher HI, Watson RC, Geller N. Ahmed T, et al. Among authors: watson rc. J Urol. 1985 Apr;133(4):602-4. doi: 10.1016/s0022-5347(17)49106-3. J Urol. 1985. PMID: 3981708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page